NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $25,000 | -86.6% | 1,505 | -81.4% | 0.00% | -90.0% |
| Q2 2020 | $187,000 | -40.3% | 8,078 | -44.3% | 0.01% | -16.7% |
| Q4 2019 | $313,000 | +7725.0% | 14,506 | +14406.0% | 0.01% | – |
| Q2 2019 | $4,000 | -82.6% | 100 | -73.1% | 0.00% | -100.0% |
| Q3 2018 | $23,000 | -92.6% | 372 | -87.3% | 0.00% | -95.7% |
| Q1 2018 | $312,000 | +5100.0% | 2,937 | +2927.8% | 0.02% | – |
| Q4 2017 | $6,000 | -98.5% | 97 | -99.4% | 0.00% | -100.0% |
| Q3 2017 | $398,000 | -55.4% | 16,587 | -63.7% | 0.04% | -57.6% |
| Q2 2017 | $893,000 | +116.7% | 45,683 | +160.0% | 0.08% | +117.9% |
| Q1 2017 | $412,000 | +118.0% | 17,569 | +14.3% | 0.04% | +69.6% |
| Q4 2016 | $189,000 | +20.4% | 15,368 | +39.1% | 0.02% | +4.5% |
| Q2 2016 | $157,000 | -13.3% | 11,048 | -16.1% | 0.02% | -12.0% |
| Q1 2016 | $181,000 | -78.2% | 13,172 | -73.3% | 0.02% | -80.6% |
| Q4 2015 | $831,000 | +164.6% | 49,339 | +72.3% | 0.13% | +180.4% |
| Q3 2015 | $314,000 | -41.2% | 28,633 | -33.0% | 0.05% | -38.7% |
| Q2 2015 | $534,000 | +81.6% | 42,711 | +59.9% | 0.08% | +82.9% |
| Q1 2015 | $294,000 | -31.5% | 26,711 | -3.4% | 0.04% | -34.9% |
| Q4 2014 | $429,000 | +31.6% | 27,663 | +2.4% | 0.06% | +37.0% |
| Q3 2014 | $326,000 | -17.5% | 27,013 | -12.3% | 0.05% | -11.5% |
| Q2 2014 | $395,000 | -35.5% | 30,785 | -39.0% | 0.05% | -36.6% |
| Q1 2014 | $612,000 | +132.7% | 50,505 | +117.6% | 0.08% | +90.7% |
| Q4 2013 | $263,000 | +8.7% | 23,212 | 0.0% | 0.04% | +10.3% |
| Q3 2013 | $242,000 | -64.0% | 23,212 | -60.1% | 0.04% | -72.9% |
| Q2 2013 | $673,000 | -32.2% | 58,235 | -35.5% | 0.14% | -22.2% |
| Q1 2013 | $993,000 | – | 90,235 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |